This recent safety and effectiveness data regarding mpox vaccination with Jynneos is important and timely given the ongoing ...

Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV vaccine in Africa, where the burden of the virus is still being keenly felt.

Why not all African countries should venture into vaccine business ANALYSIS | The African Union has embarked on one of its ...

A groundbreaking project to study potential HIV vaccines in several ... to the development of SARS-CoV-2 vaccines made by the pharmaceutical companies Moderna and Pfizer/BioNTech.

Vaccine makers were hit particularly hard yesterday, as Marks’ resignation letter alluded to disagreements with HHS Secretary ...

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...

MORE: Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS The opposition ... from melanoma to HIV to Zika, according to clinical trials. The proposed bans ...

Last year, Moderna and the National Institutes of Health in the US started clinical trials of multiple mRNA-based HIV vaccine candidates, including some intended for use in combination ...

A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in funding from the US government. As a result, several promising vaccine ...

Whereas the Pfizer and Moderna COVID-19 vaccines suspend mRNA ... in the general coronaviruses,” she says. Related: Another HIV vaccine fails, highlighting longstanding challenges in the field ...

In what some at the agency view as an ominous sign, the NIH's acting director Dr. Matthew Memoli also requested information last week about the funding that supports mRNA vaccine research, technology ...